Table 4.

Tumor recurrence details of the study patients

	Long-term survivors (n = 7)	Short-term survivors (n = 36)	P-value
Recurrence timing			0.009
< 1 year	1 (14.3%)	24 (66.7%)
1-2 years	2 (28.6%)	7 (19.4%)
2-5 years	3 (42.9%)	5 (13.9%)
> 5 years	1 (14.3%)	0 (0.0%)
Recurrence location			0.04
Regional	5 (71.4%)	11 (30.6%)
Metastatic	2 (28.6%)	25 (69.4%)
Recurrence treatment			< 0.001
Resection	3 (42.9%)	5 (13.9%)
Resection + chemo/radiation	4 (57.1%)	4 (11.1%)
Chemo/radiation only	0 (0.0%)	10 (27.8%)
Supportive only	0 (0.0%)	17 (47.2%)

n.s. Not significant